Literature DB >> 2044599

Persistent hyperthyrotropinaemia since the neonatal period in clinically euthyroid children.

L A Tyfield1, S S Abusrewil, S R Jones, D C Savage.   

Abstract

We describe three children, now aged between 5 and 6 years, with a persistent mild hyperthyrotropinaemia since the neonatal period and normal levels of thyroid hormones. The increased thyroid stimulating hormone concentration is not artefactual and is not caused by antibody interferences. Their growth and development is normal and none has received thyroid hormone replacement. We believe that they have compensated hypothyroidism, and that before the advent of screening for congenital hypothyroidism these children would have presented in mid-childhood with juvenile hypothyroidism.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2044599     DOI: 10.1007/bf01955927

Source DB:  PubMed          Journal:  Eur J Pediatr        ISSN: 0340-6199            Impact factor:   3.183


  8 in total

1.  Incidence and specificity of interference in two-site immunoassays.

Authors:  L M Boscato; M C Stuart
Journal:  Clin Chem       Date:  1986-08       Impact factor: 8.327

2.  Falsely elevated serum thyrotropin (TSH) in newborn infants: transfer from mothers to infants of a factor interfering in the TSH radioimmunoassay.

Authors:  D Gendrel; M C Feinstein; J Grenier; M Roger; J Ingrand; J L Chaussain; P Canlorbe; J C Job
Journal:  J Clin Endocrinol Metab       Date:  1981-01       Impact factor: 5.958

3.  Transient hypothyroidism in the newborn infant.

Authors:  F Delange; J Dodion; R Wolter; P Bourdoux; A Dalhem; D Glinoer; A M Ermans
Journal:  J Pediatr       Date:  1978-06       Impact factor: 4.406

4.  Transient infantile hyperthyrotropinaemia. Report of a case.

Authors:  K Miyai; N Amino; K Nishi; T Fujie; K Nakatani; O Nose; T Harada; H Yabuuchi; K Doi; T Yamamoto; R Satake; T Tsuruhara; T Oura
Journal:  Arch Dis Child       Date:  1979-12       Impact factor: 3.791

5.  Screening for congenital hypothyroidism: results of screening one million North American infants.

Authors:  D A Fisher; J H Dussault; T P Foley; A H Klein; S LaFranchi; P R Larsen; M L Mitchell; W H Murphey; P G Walfish
Journal:  J Pediatr       Date:  1979-05       Impact factor: 4.406

6.  Serum thyroxine and thyroid stimulating hormone concentrations after treatment of congenital hypothyroidism.

Authors:  S S Abusrewil; L Tyfield; D C Savage
Journal:  Arch Dis Child       Date:  1988-11       Impact factor: 3.791

7.  Transient neonatal hyperthyrotrophinaemia: a serum abnormality due to transplacentally acquired antibody to thyroid stimulating hormone.

Authors:  J H Lazarus; R John; J Ginsberg; I A Hughes; G Shewring; B R Smith; J S Woodhead; R Hall
Journal:  Br Med J (Clin Res Ed)       Date:  1983-02-19

8.  Transient neonatal hyperthyrotropinemia: a factitious syndrome due to the presence of heterophilic antibodies in the plasma of infants and their mothers.

Authors:  P Czernichow; J L Vandalem; G Hennen
Journal:  J Clin Endocrinol Metab       Date:  1981-08       Impact factor: 5.958

  8 in total
  3 in total

1.  Performance metrics after changes in screening protocol for congenital hypothyroidism.

Authors:  Steven J Korzeniewski; Violanda Grigorescu; Mary Kleyn; William Young; Gretchen L Birbeck; David Todem; Roberto Romero; Tinnakorn Chaiworapongsa; Nigel Paneth
Journal:  Pediatrics       Date:  2012-10-08       Impact factor: 7.124

2.  Are preterm newborns who have relative hyperthyrotropinemia at increased risk of brain damage?

Authors:  Steven J Korzeniewski; Carmen L Soto-Rivera; Raina N Fichorova; Elizabeth N Allred; Karl C K Kuban; T Michael O'Shea; Nigel Paneth; Michael Agus; Olaf Dammann; Alan Leviton
Journal:  J Pediatr Endocrinol Metab       Date:  2014-11       Impact factor: 1.634

3.  Update on Neonatal Isolated Hyperthyrotropinemia: A Systematic Review.

Authors:  Ana E Chiesa; Mariana L Tellechea
Journal:  Front Endocrinol (Lausanne)       Date:  2021-08-18       Impact factor: 5.555

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.